NPT system for leucoreduced plasma, buffy coat
and leucoreduced Red Blood Cells concentrate preparation
In-line plasma filter
Leukodepletion is a major step to improve transfusion safety thanks to a significant reduction of patient adverse reactions and pathogen transmissions.
Macopharma develops and manufactures leukodepletion systems to improve the quality and the safety of blood components, allowing better patient outcome.
Benefits
High leukodepletion performance
Plasmaflex Miniplas provides high performance far below the Europeanrequirement 1 x 106/unit WBC/unit
Compliance with all the European guidelines parameters for fresh frozen plasma
High blood component recovery > 95%
Allow plasma cells and fragment removal
Maintain plasma biochemical and labile coagulation factors
Features
Soft housing filter for easy & secure handling
Design allowing transparent housing for visual monitoring of filtration
Fast filtration process
Quality
Macopharma is a major global player in the filtration of blood components, with unique know-howand expertise. We have a deep understanding of your requirements and strive to provide you with reliable and robust filters, guaranteeing high performance stability and reproducibility.
This information is for exclusive use of healthcare professionals.
The products are not available in every country, please contact your sales representative.
MACOPHARMA • Rue Lorthiois 59240 Mouvaux France • Tel : + 33 (0) 3 20 11 84 00 • Fax : +33 (0) 3 20 11 84 03
Société par actions simplifiée au Capital de 493.115 € RCS Lille Metropole 391 600 905 • Code APE 4641 Z • TVA FR 313 916 009 05